Remote Ischemic Conditioning (RIC) for Cerebral Palsy
Study Summary
This trial is testing whether a new priming agent can help children with UCP learn new bimanual skills and improve their hand function.
- Unilateral Cerebral Palsy
- Remote Ischemic Conditioning
- Cerebral Palsy
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is there an opportunity for me to partake in this clinical exploration?
"To qualify for this medical trial, candidates must be between 6 and 16 years old with a diagnosis of paralysis. The study is seeking to recruit roughly 30 individuals."
Are there any vacancies left to participate in this experiment?
"According to the clinicaltrials.gov, this medical trial is still accepting participants. It was first announced on December 18th 2021 and underwent an update as recently as April 30th 2022."
What objectives are being pursued through this clinical experiment?
"The primary outcome to be evaluated over a baseline and 1 week duration is the Change in Assisting Hand Assessment (AHA). Secondary metrics include variations of manual speed, dexterity and balance performance. These are measured with Box & Block Test (BBT), Nine-Hole Peg Test (NHPT) and average amount of time standing on stability platform respectively."
How many participants are involved in this research endeavor?
"Affirmative. Clinicaltrials.gov details that this medical research project, which was first published on December 18th 2021, is in the process of enrolling participants. A total of 30 subjects are sought after at only one trial centre."
Has Remote Ischemic Conditioning been sanctioned by the Food and Drug Administration?
"Our team at Power assessed the safety of Remote Ischemic Conditioning (RIC) as a 2, for this Phase 2 trial implies that it has some evidence supporting its security but not necessarily efficacy."
Is this study accepting participants of all ages, including those younger than 65 years old?
"As per the parameters of this trial, individuals between 6 and 16 years old can be enrolled."